ScreenerHero

SANION Saniona AB (publ)

STO · SE · Healthcare · Biotechnology · saniona.com
9.300SEK-3.02%Mkt Cap: 122.79M $P/E: 7.21

Saniona AB (publ), a clinical-stage biopharmaceutical company, focuses on discovering, developing, and delivering innovative treatments for neurological and psychiatric disorders in Ireland, the United States, Germany, D…

Industry Peers

Biotechnology
Screen all
VRTX
Vertex Pharmaceuticals Incorporated
$127.24BUSDP/E 29.3
REGN
Regeneron Pharmaceuticals, Inc.
$76.05BUSDP/E 18.3
MRNA
Moderna, Inc.
$74.84BUSD
ARGX
argenx SE
$56.77BUSDP/E 37.1
ARGX
argenx SE
$58.21BUSDP/E 35.5
UCB
UCB SA
$41.93BUSDP/E 17.9
RVMD
Revolution Medicines, Inc.
$42.84BUSD
ONC
BeOne Medicines AG
$41.27BUSDP/E 64.9
RPRX
Royalty Pharma plc
$32.61BUSDP/E 30.0
ALNY
Alnylam Pharmaceuticals, Inc.
$29.97BUSDP/E 37.8
ROIV
Roivant Sciences Ltd.
$25.66BUSD
BNTX
BioNTech SE
$24.05BUSD
GMAB
Genmab A/S
$23.24BUSDP/E 29.8
INSM
Insmed Incorporated
$22.98BUSD
GMAB
Genmab A/S
$22.23BUSDP/E 30.6
INCY
Incyte Corporation
$22.85BUSDP/E 14.4
JAZZ
Jazz Pharmaceuticals plc
$15.02BUSDP/E 15.9
ASND
Ascendis Pharma A/S
$14.87BUSDP/E 17.3
EXEL
Exelixis, Inc.
$14.45BUSDP/E 18.4
SMMT
Summit Therapeutics Inc.
$13.81BUSD

Key Statistics

Company
Market Cap122.79M USD
Enterprise Value80.16M USD
Revenue (TTM)40.61M USD
Gross Profit41.03M USD
Net Income (TTM)27.23M USD
Revenue/Share3.10 SEK
Last Price9.300 SEK
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees44
CountrySE
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)7.21
P/E (Forward)—
PEG—
EV/EBITDA4.12
EV/Revenue1.97
P/S3.12
P/B2.42
EPS (TTM)1.29
EPS (Forward)—
52W Range
9.1301% of range28.30
52W High28.30 SEK
52W Low9.130 SEK
Profitability
Gross Margin98.75%
Oper. Margin-1292.55%
EBITDA Margin47.96%
Profit Margin65.53%
ROE44.82%
ROA41.88%
Growth
Revenue Growth-51.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF26.19M USD
CapEx (TTM)7.04M USD
FCF Margin28.12%
FCF Yield9.30%
Net Debt-46.52M USD
Net Debt/EBITDA-2.39
Balance Sheet
Debt/Equity0.00
Current Ratio9.65
Quick Ratio9.30
Book Value/Sh3.97 SEK
Cash/Share3.52 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 SEK
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)19.00 SEK
Upside (mean)+104.3%
Target Range19.00 SEK – 19.00 SEK
# Analysts1
Ownership
Shares Out.138.03M
Float121.28M
Insiders7.64%
Institutions24.12%
Technical
SMA 5011.70 (-20.5%)
SMA 20015.70 (-40.8%)
Beta1.20
S&P 52W Chg14.58%
Avg Vol (30d)452.77K
Avg Vol (10d)382.11K
Technical Indicators
RSI (14)30.7
MACD-0.5782
MACD Signal-0.6274
MACD Hist.+0.0492
BB Upper10.71 SEK
BB Middle9.905 SEK
BB Lower9.104 SEK
BB Width16.19%
ATR (14)0.4909 SEK
Vol Ratio (20d)1.33x